Please login or register to print this page.

News & Views

Special groups: diabetes

Data from the PREFER in AF patient registry has shown that patients with atrial fibrillation (AF) and diabetes on insulin treatment are at a significantly increased risk of stroke/systemic embolism compared to both AF patients without diabetes and AF patients with diabetes but not on insulin treatment.1

At one year follow up, AF patients with diabetes on insulin treatment had a risk of 5.2% compared to a 1.9% risk for AF patients without diabetes (HR 2.89, p = 0.0002) and a 1.8% risk for patients with diabetes but not on insulin treatment (HR 2.96, p= 0.0019). This latter group of patients had a similar incidence of thromboembolic events than patients without diabetes (HR 1.49–5.87, p = 0.0019).

Reference

1. Ricottini E et al. Insulin- requiring diabetes and thromboembolic risk  in patients with atrial fibrillation: a PREFER in AF Registry substudy. Abstract P2596. Eur Heart J 2016;37 (Abstract supplement):509-10.

Published on: October 19, 2016

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.